SYNAPLIN

Swiss trademark · 579112 · Word mark · Deleted

Register entry

Registration number
579112
Application number
58730/2008
Status
Deleted
Type
Word mark
Filed
Jul 11, 2008
Registered
Nov 12, 2008
Published
Nov 12, 2008
Deleted
Feb 19, 2019
Reason
Not renewed
Priority
13.02.2008 US
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Päparate für die Behandlung von autoimmunen Störungen, neurologischen Störungen, kardiovaskularen Störungen, onkologischen Störungen, Multiple Sklerose, Morbus Crohn, rheumatischer Arthritis, Wirt-gegen-Transplantat-Reaktionen oder Transplantat-gegen-Wirt-Reaktionen und Transplantatabstossungen bei mitochondrialen Erkrankungen.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 19, 2019

    Deleted, not renewed

    Published in Swissreg on 19.02.2019

  2. May 24, 2016

    Holder’s address changed

    Owner
    Biogen Idec MA Inc., 14 Cambridge Center, MA 02142 Cambridge, USA → Biogen MA Inc., 250 Binney Street, Cambridge, MA 02142, USA

    Published in Swissreg on 24.05.2016

  3. Nov 12, 2008

    Registered

    Published in Swissreg on 12.11.2008

Parties

Holder

Biogen MA Inc.

250 Binney Street, Cambridge, MA 02142, US

Agent

E. Blum & Co. AG

E. Blum & Co. AG Patent- und Markenanwälte VSP

Vorderberg 11, 8044 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.